Novogen Limited
(NASDAQ:NVGN)|
2.90 +0.20 (7.41%) 12:26ET Delayed |
|
|
|
- Compare NVGN with:
- View: Line | Candlestick
Company Profile
Novogen Limited
140 Wicks Road
North Ryde, NSW, 2113
Australia - Map
Phone: 61298780088
Fax: 61298780055
Website: www.novogen.com
CEO: Christopher Naughton
Employees: 66
Sector: Healthcare
Industry Group: Drugs
Industry: Drug Manufacturers - Major
Pharmaceutical Preparations Company
A pharmaceutical company which is involved in the discovery, development, manufacture and marketing of products based on the emerging field of isoflavonoid technology.
Recent news for NVGN
-
Marshall Edwards, Inc. Files IND Application for Triphendiol
Marketwire - 4 hours ago
-
Briefing.com - 4 hours ago
-
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
Marketwire - Nov 13 at 8:10 ET
-
Independent Data Monitoring Committee Recommends Marshall Edwards, Inc.'s OVATURE Trial Continue
Marketwire - Nov 12 at 8:10 ET
-
Marketwire - Oct 30 at 6:18 ET
-
Old Point Financial, Oshkosh and Catapult Communications lead small-cap percentage gainers
SmallCapInvestor.com - Sep 26 at 11:25 ET
-
Preliminary 2008 Novogen Earnings Release - Time Not Supplied
CCBN - Sep 23 at 6:07 ET
-
Seabridge Gold, NovaGold Resources and Hoku Scientific lead small-cap percentage gainers
SmallCapInvestor.com - Sep 17 at 11:39 ET
-
Marshall Edwards, Inc. to Present at the Canaccord Adams 28th Annual Global Growth Conference
Marketwire - Aug 11 at 7:15 ET